#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Retinitis pigmentosa Fibrosarcoma Follicular lymphoma stage II Usher's syndrome Narcolepsy Insulinoma Multiple system atrophy Retinal dystrophy Neurofibroma Follicle centre lymphoma follicular grade I, II – III Small for dates baby Epilepsy Bulbospinal muscular atrophy congenital Rett syndrome Cluster headache More trials…
Learn about Rare Diseases

Hepatic angiosarcoma – Treatment Chordoma – Life with Disease Aicardi-Goutieres syndrome – Treatment Crigler-Najjar syndrome – Trials in Disease Vascular malformation – Diagnostics Osteosarcoma recurrent – Diagnostics Lymphatic malformation – Diagnostics Ewing’s sarcoma metastatic – Diagnostics Biotinidase deficiency – Trials in Disease Basal cell naevus syndrome – Life with Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Rbl027.2 Orlistat Povidone, Iodinated Sotagliflozin Lorazepam Trometamol Gad20-209-Fsp-A4 Gsk4011499 Eculizumab Flecainide Acetate Alpha1H Pyridoxine Hydrochloride Abiraterone Eftilagimod Alfa Zidovudine Gliquidone Efavirenz Betula Pendula Pollen Extract Zoledronic Acid Daunorubicin Hydrochloride More therapies…

Learn about Your Condition

Psychogenic seizure Thrombocytopenia Chronic disease Stargardt's disease Corneal graft rejection Post procedural infection Trigeminal neuralgia Cutibacterium acnes infection Cardiac amyloidosis Irritable bowel syndrome Meningorrhagia Ligament sprain Pancreatic fistula Breast cancer stage I Diabetic retinal oedema More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Philadelphia positive acute lymphocytic leukaemia

Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Recruiting

3 1 1 1
Investigated Diseases:
- Philadelphia positive acute lymphocytic leukaemia
- Acute lymphocytic leukaemia
Investigated Drugs:
+3
Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Not recruiting

3 1 1 1
Investigated Diseases:
- Philadelphia positive acute lymphocytic leukaemia
Investigated Drugs:
Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Not recruiting

3 1 1 1
Investigated Drugs:
- Imatinib
- Ponatinib

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Philadelphia positive acute lymphocytic leukaemia

Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies